Notis Mc Conarty Edward Abbott Laboratories Transaction History

Notis Mc Conarty Edward

$252 Million
Q2 2024

A detailed history of Notis Mc Conarty Edward transactions in Abbott Laboratories stock. As of the latest transaction made, Notis Mc Conarty Edward holds 73,367 shares of ABT stock, worth $8.35 Million. This represents 3.03% of its overall portfolio holdings.

Number of Shares

73,367

Previous 74,970 2.14%

Holding current value

$8.35 Million

Previous $8.52 Million 10.54%

% of portfolio

3.03%

Previous 3.41%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$100.73 - $112.44 $161,470 - $180,241	-1,603 Reduced 2.14%	73,367 $7.62 Million
Q1 2024 Apr 29, 2024	SELL	$109.52 - $120.96 $618,788 - $683,424	-5,650 Reduced 7.01%	74,970 $8.52 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $5,321 - $6,513	59 Added 0.07%	80,620 $8.87 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $32,862 - $39,429	-344 Reduced 0.43%	80,561 $7.8 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $70,646 - $78,715	-701 Reduced 0.86%	80,905 $8.82 Million
Q1 2023 May 10, 2023	SELL	$96.86 - $114.01 $193 - $228	-2 Reduced -0.0%	81,606 $8.26 Million
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $3,517 - $4,126	37 Added 0.05%	81,608 $8.96 Million
Q3 2022 Nov 08, 2022	SELL	$96.76 - $112.03 $9,482 - $10,978	-98 Reduced 0.12%	81,571 $7.89 Million
Q2 2022 Jul 19, 2022	BUY	$102.07 - $123.37 $12,350 - $14,927	121 Added 0.15%	81,669 $8.87 Million
Q1 2022 May 17, 2022	SELL	$114.02 - $139.04 $113,449 - $138,344	-995 Reduced 1.21%	81,548 $9.65 Million
Q4 2021 Feb 08, 2022	SELL	$115.53 - $141.46 $77,289 - $94,636	-669 Reduced 0.8%	82,543 $11.6 Million
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $176,739 - $195,525	1,515 Added 1.85%	83,212 $9.83 Million
Q2 2021 Aug 09, 2021	SELL	$105.79 - $124.53 $69,504 - $81,816	-657 Reduced 0.8%	81,697 $9.47 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $59,100 - $69,628	543 Added 0.66%	82,354 $9.87 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $255,150 - $278,040	-2,430 Reduced 2.88%	81,811 $8.96 Million
Q3 2020 Oct 28, 2020	SELL	$91.64 - $111.29 $161,561 - $196,204	-1,763 Reduced 2.05%	84,241 $9.17 Million
Q2 2020 Jul 28, 2020	SELL	$76.57 - $98.0 $129,020 - $165,130	-1,685 Reduced 1.92%	86,004 $7.86 Million
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $130,665 - $191,068	-2,080 Reduced 2.32%	87,689 $6.92 Million
Q4 2019 Jan 15, 2020	SELL	$78.51 - $87.4 $78,510 - $87,400	-1,000 Reduced 1.1%	89,769 $7.8 Million
Q3 2019 Nov 04, 2019	SELL	$81.84 - $88.74 $149,358 - $161,950	-1,825 Reduced 1.97%	90,769 $7.59 Million
Q2 2019 Jul 24, 2019	SELL	$72.88 - $85.0 $192,111 - $224,060	-2,636 Reduced 2.77%	92,594 $7.79 Million
Q1 2019 Apr 29, 2019	SELL	$66.22 - $80.06 $54,962 - $66,449	-830 Reduced 0.86%	95,230 $7.61 Million
Q4 2018 Jan 24, 2019	BUY	$65.56 - $74.27 $285,841 - $323,817	4,360 Added 4.75%	96,060 $6.95 Million
Q3 2018 Oct 15, 2018	BUY	$60.81 - $73.36 $60,810 - $73,360	1,000 Added 1.1%	91,700 $6.73 Million
Q2 2018 Jul 30, 2018	BUY	$57.57 - $63.54 $16,119 - $17,791	280 Added 0.31%	90,700 $5.53 Million
Q1 2018 Apr 24, 2018	BUY	$56.27 - $63.62 $45,578 - $51,532	810 Added 0.9%	90,420 $5.42 Million
Q4 2017 Feb 02, 2018	BUY	$53.68 - $57.47 $257,127 - $275,281	4,790 Added 5.65%	89,610 $5.11 Million
Q3 2017 Oct 26, 2017	BUY	$48.06 - $53.64 $4.08 Million - $4.55 Million	84,820	84,820 $4.53 Million

Others Institutions Holding ABT

# of Institutions

3,131

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Notis Mc Conarty Edward, based on Form 13F filings with the SEC.

News

Stay updated on Notis Mc Conarty Edward with notifications on news.

Account

Notis Mc Conarty Edward Abbott Laboratories Transaction History